Instil Bio TIL
NASDAQ TIL
$5.69 -0.01 (-0.18%)
As of: Oct 23, 2026 · 3:05 PM EDT

Instil Bio (TIL) EBITDA Margin (2020)

Updated

Instil Bio's EBITDA Margin came in at -24194.20% for FY2020.

Analysis

Instil Bio (TIL) EBITDA Margin (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,130.46 Bn 1,099.05 Bn 19.71 Bn 53.49%
2 Johnson & Johnson 635.24 Bn 555.11 Bn 17.30 Bn 32.68%
3 AbbVie 504.85 Bn 477.96 Bn 12.70 Bn 49.01%
4 Merck 358.66 Bn 313.04 Bn 12.21 Bn 6.02%
5 Novartis Ag 290.32 Bn 254.31 Bn 11.24 Bn -
6 Astrazeneca 265.28 Bn 238.97 Bn 12.86 Bn 33.11%
7 Amgen 237.85 Bn 193.25 Bn 7.24 Bn 46.01%
8 Gilead Sciences 194.96 Bn 169.16 Bn 6.22 Bn -124.26%
9 Pfizer 171.51 Bn 118.16 Bn 10.94 Bn 39.16%
10 Instil Bio 38.59 Mn 15.59 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 -14,700.00%
Jun 30, 2020 -10,854.76%
Mar 31, 2020 -8,763.64%
API Access

Instil Bio EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=TIL&period=max&api_key=YOUR_API_KEY